Capital for laboratory buildings, R&D campuses, biotech facilities, and GMP manufacturing
Life sciences real estate has emerged as one of the highest-conviction sectors in commercial real estate, fueled by record levels of biotech funding, an aging population driving pharmaceutical demand, and the essential nature of laboratory space that cannot be replicated remotely. George Smith Partners provides capital solutions across the life sciences property spectrum.
We understand the specialized infrastructure requirements, tenant credit dynamics, and cluster-driven demand that define life sciences underwriting. Our relationships span institutional lenders, life companies, construction lenders, debt funds, and equity partners with deep life sciences expertise.
Purpose-built wet and dry laboratory space for biotech, pharmaceutical, and research tenants.
Multi-building research campuses combining lab, office, and collaboration space for life sciences tenants.
Good Manufacturing Practice facilities for pharmaceutical and biologic production with specialized cleanroom infrastructure.
Office-to-lab or industrial-to-lab conversions requiring upgraded mechanical systems and infrastructure.
Shared laboratory facilities for early-stage life sciences companies with flexible lease terms.
Temperature-controlled distribution and cold storage facilities for pharmaceutical logistics.
Financing is available for the full range of life sciences real estate, including wet and dry laboratory buildings, R&D campuses, biotech incubators, GMP manufacturing facilities, clean rooms, pharmaceutical distribution centers, and mixed-use life sciences office/lab buildings. Each sub-type has unique infrastructure requirements that affect construction cost, lease terms, and underwriting.
Life sciences lenders evaluate tenant credit quality (publicly traded biotech vs. early-stage startup), lease duration and structure, the cost and specificity of tenant improvements, proximity to research institutions and talent clusters, the building's infrastructure (HVAC, power, ventilation), and the broader market fundamentals of the life sciences cluster. Properties with investment-grade tenants on long-term leases in top-tier clusters attract the most competitive terms.
Lab conversions involve retrofitting traditional office or industrial buildings for life sciences use, including upgraded mechanical systems, increased floor loads, specialized ventilation, and laboratory-grade utilities. Financing typically involves a construction or bridge loan during the conversion period, followed by permanent financing upon lease-up. Lenders evaluate the conversion cost basis, the target market's lab supply-demand dynamics, and pre-leasing activity.
The top U.S. life sciences clusters include Boston/Cambridge, the San Francisco Bay Area, San Diego, the Research Triangle in North Carolina, suburban Maryland near the NIH, and New Jersey. However, emerging markets such as Philadelphia, Seattle, Denver, and Austin are attracting growing life sciences investment as companies seek lower-cost alternatives with access to research universities and talent.
Our team can help you secure financing for your life sciences real estate investment.
Discuss Your Life Sciences Financing